Parkman Healthcare Partners’s LivaNova LIVN Stock Holding History

Parkman Healthcare Partners’s Portfolio LIVN Stock Details LIVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.3M	Sell	210,529 -193,436	-48%	-$13.7M	1.77%	22
2026 Q1	$25.7M	Sell	403,965 -6,947	-2%	-$448K	2.65%	11
2025 Q4	$25.3M	Buy	410,912 +135,101	+49%	+$7.72M	2.41%	11
2025 Q3	$14.4M	Buy	275,811 +100,811	+58%	+$5.07M	1.51%	21
2025 Q2	$7.88M	Buy	175,000 +8,129	+5%	+$335K	0.91%	40
2025 Q1	$6.55M	Sell	166,871 -8,063	-5%	-$362K	0.78%	44
2024 Q4	$8.1M	Buy	174,934 +73,205	+72%	+$3.75M	1.08%	34
2024 Q3	$5.34M	Buy	101,729 +16,570	+19%	+$821K	0.68%	50
2024 Q2	$4.67M	Sell	85,159 -59,841	-41%	-$3.41M	0.63%	56
2024 Q1	$8.11M	Buy	+145,000	New	+$7.53M	1%	37

Other funds holding LIVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Parkman Healthcare Partners's LIVN Position: Q2 2026 in Review

Parkman Healthcare Partners reduced its LivaNova (LIVN) stake by 48% in Q2 2026, selling an estimated $13.7M and leaving 210,529 shares worth $17.3M. The position accounts for 1.77% of the portfolio, ranked #22.

Parkman Healthcare Partners first reported a position in LIVN in Q1 2024 and has held it in 10 quarters since. The position peaked at $25.7M in Q1 2026. 303 funds tracked by Wall St. Rank hold LIVN as of Q2 2026.

Parkman Healthcare Partners held 210,529 shares of LivaNova worth $17.3M as of Q2 2026.
Parkman Healthcare Partners sold 193,436 LivaNova shares in Q2 2026, an estimated $13.7M.
LivaNova made up 1.77% of Parkman Healthcare Partners's portfolio in Q2 2026, its #22 holding.
Parkman Healthcare Partners first reported a position in LivaNova in Q1 2024 and has held it in 10 quarters since.
Parkman Healthcare Partners's LivaNova position peaked at $25.7M in Q1 2026.
303 funds tracked by Wall St. Rank held LivaNova as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.